IPO Profile

Syneron Medical
Industrial Zone, Yokneam Illit, 20692, P.O.B 550, Israel
Tel: 97-24-909-6200
Web: www.syneron.com
Ticker: ELOS
Stock Exchange: Nasdaq
Shares Issued: 5,500,000.00
Price Offered: $12.00
Amount Raised: $66,000,000.00

Underwriters:
Citigroup Global Markets
CIBC World Markets
Stephens & Co.



Company Description:
We design, develop and market innovative aesthetic medical products based on our proprietary Electro-Optical Synergy, or ELOS technology, which uses the synergy between electrical energy and optical energy to provide effective, safe and affordable aesthetic medical treatments. Our products, which we sell primarily to physicians and other practitioners, target a wide array of non-invasive aesthetic medical procedures, including hair removal, wrinkle reduction and rejuvenating the skin�s appearance through the treatment of superficial benign vascular and pigmented lesions. We believe ELOS provides performance advantages over existing technologies that rely solely on optical energy. We believe using optical energy alone limits the safety and efficacy of many aesthetic medical procedures due to limited skin penetration and unwanted epidermal absorption. Our proprietary ELOS technology combines optical energy, energy derived from light waves, with electrical energy, in particular radiofrequency energy, which results from the flow of electric charge through a conductor. This combination enhances the user�s ability to target accurately the tissue to be treated and enables real-time measurement of skin temperature, resulting in increased patient safety and comfort and improved treatment results.